CLGN (collplant.com) Short-Term Debt to Capital

Corporate emblem and logo of CollPlant Biotechnologies (CLGN)

CollPlant Biotechnologies (CLGN) is developing a unique system for synthesizing human protein from flora, securing privileged contracts with leading aesthetic surgeons. The business relies on the creation of rhCollagen bio-inks for the B2B tissue 3D printing segment, which ensures high technological protection. The asset's market value dynamics, reaching 0.31, illustrate the trajectory of a biotech leader combining natural resources and innovation for organ restoration and wound healing.

CLGN - CollPlant Biotechnologies Ltd. Short-Term Debt to Capital over the range 07/04/2022 - 10/29/2026

Metric breakdowns and analytics for CollPlant Ltd (CLGN)

- stock value and consensus price forecast:
Price Chart CollPlant Biotechnologies|CLGN - Fair Value Consensus
- business market valuation indicators:
Market Capitalization CollPlant|CLGN - Total Enterprise Value
- book capitalization information:
Book Value per Share CollPlant Biotechnologies|CLGN - Book Capitalization|Market Cap to Net Assets Ratio collplant.com|CLGN - Aggregate Business Assets
- debt level and financial liquidity data:
Debt to Equity CollPlant Biotechnologies|CLGN - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital CollPlant Biotechnologies|CLGN - Company Cumulative Debt|Debt to Book Capitalization Ratio CollPlant|CLGN - Company Long-Term Indebtedness|Company Current Liabilities CollPlant Biotechnologies|Quick Ratio collplant.com
- earnings and market ratios statistics:
CLGN - Net Income
Analysis of all company metrics:CLGN CollPlant Biotechnologies Ltd.
Signature product of CollPlant Ltd

Assessing the financial stability of CollPlant Biotechnologies (CLGN) requires an analysis of liquidity amid a moderate dependence on external research partners. This indicator measures the ratio of short-term liabilities to equity, while the share of short-term loans in the company's capital determines the speed of balance sheet adaptation to crises and the degree of asset loss risk during a sharp deterioration in market conditions.

Who CollPlant Biotechnologies competes with

Short-Term Debt to Equity HCA Healthcare, Inc. (HCA)|THC (Tenet Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital FMS (Fresenius Medical Care)|solventum.com (SOLV) - Current Liabilities to Capital|Encompass Health Corporation - Short-Term Debt to Capital|UHS - Short-Term Debt to Capital|DVA (DaVita Inc) - Short-Term Debt to Equity Ratio|RDNT: Short-Term Loans to Capital Ratio|Short-Term Debt to Equity Option Care Health|Short-Term Debt to Equity Ratio surgerypartners.com (SGRY)|Short-Term Debt to Capital PINC|EYE - Current Liabilities to Capital|Short-Term Debt to Equity Progyny Health PGNY|ARDT: Short-Term Debt to Capital Ratio|SEM: Short-Term Debt to Equity Ratio|astranahealth.com - Short-Term Loans to Capital Ratio|MD: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio U.S. Physical Therapy, Inc.|Short-Term Debt to Equity Pennant Group Inc|Current Liabilities to Capital Organogenesis Corp ORGO|Short-Term Debt to Equity Nutex Health Inc. (NUTX)|Short-Term Debt to Equity AUNA (aunainvestors.com)|Short-Term Debt to Equity SBC Medical Group Holdings SBC|Evolus Inc - Short-Term Debt to Equity|CYH - Short-Term Debt to Equity|Current Liabilities to Equity SKIN|mediwound.com (MDWD) - Short-Term Debt to Equity|BTMD (biote.com) - Short-Term Debt to Equity|JYNT (The Joint Chiropractic) - Short-Term Debt to Capital|Short-Term Debt to Capital DocGo, Inc.|Short-Term Debt to Equity P3 Health Partners Inc. (PIII)|gaintherapeutics.com - Short-Term Debt to Capital Ratio|EUDA Health Holdings Limited - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio BMGL (Basel Medical)|CUPR: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital CCM (Concord Medical Services Holdings)|AMS: Short-Term Debt to Capital|MRM (MEDIROM Corp) - Short-Term Debt to Equity|ALBT (Avalon GloboCare Corp) - Short-Term Debt to Capital|dih.com (DHAI) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Carmell Therapeutics (XAGE)|NIVF - Current Liabilities to Capital|ATI Physical Therapy, Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio CMAX (CareMax, Inc)|Kindly MD, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital modivcare.com|NVOS: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio SunLink Health Systems, Inc.|BACK (IMAC Regeneration Centers) - Short-Term Debt to Capital